Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The potential of the use of antitude therapy in pediatric practice

Tytuł:
The potential of the use of antitude therapy in pediatric practice
Autorzy:
E. L. Rashitova
A. M. Zakirova
T. B. Moroz
D. T. Shayapova
A. G. Kadriev
A. A. Kadriev
Temat:
children
butamirate
dry cough
bronchitis
preschool age
Medicine
Źródło:
Медицинский совет, Vol 0, Iss 18, Pp 58-64 (2020)
Wydawca:
Remedium Group LLC, 2020.
Rok publikacji:
2020
Kolekcja:
LCC:Medicine
Typ dokumentu:
article
Opis pliku:
electronic resource
Język:
Russian
ISSN:
2079-701X
2658-5790
Relacje:
https://www.med-sovet.pro/jour/article/view/5895; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790
DOI:
10.21518/2079-701X-2020-18-58-64
Dostęp URL:
https://doaj.org/article/445c11194e00438b9169d374f9c918fe  Link otwiera się w nowym oknie
Numer akcesji:
edsdoj.445c11194e00438b9169d374f9c918fe
Czasopismo naukowe
Introduction.Coughing affects quality of life and is the most common reason patients seek medical attention. In children, establishing the pathophysiological cause of the condition associated with cough is of particular importance for making an adequate diagnosis and prescribing the correct therapy.Target. To assess the efficacy and safety of butamirate use in the complex treatment of preschoolers with acute bronchitis.Materials and methods. The initiative study was carried out in accordance with the requirements of the Declaration of Helsinki and included 63 patients with a dry cough symptom at the age of 3–7 years with a diagnosis of acute bronchitis. The effectiveness of therapy was assessed using a point system. In the main (1) group – 21 children – used a non-narcotic antitussive drug of central action butamirate, 5 ml of syrup 3 times/day before meals for 4,7 ± 0,6 days. In the main (2) group – 21 children – butamirate was administered at 25 drops inside 4 times/day for 4,9 ± 0,8 days. In the comparison group – 21 children – antitussives were used according to the protocol for the treatment of acute bronchitis.Results. In 80,3 ± 5,4% of patients in the main (1 and 2) groups, by the fourth day of treatment with butamirate in relation to the comparison group, the state of health improved (0,5 ± 0,07 points, p = 0,032), the intensity of cough decreased (0,1 ± 0,01 points, p = 0,015), dry cough leveled out (0,3 ± 0,02 points, p = 0,023), the cough period decreased with exhausting cough (0,2 ± 0,01 points, p = 0,017). There were no statistically significant differences between the two main groups. In no case did butamirate cause respiratory depression, impairment of cognitive functions, sedation and drug dependence. In the comparison group, the patients’ state of health improved less intensely, the characteristics of dry cough persisted for a longer time.Conclusions. Butamirate is effective and safe in the treatment of dry cough in acute bronchitis in preschoolers.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies